Penile Traction After Prostatectomy
Evidence-based penile rehabilitation using FDA-registered traction therapy to preserve penile length, prevent tissue contracture, and support erectile function recovery after prostate surgery.
🏥 Key Facts
- Post-Prostatectomy Penile Shortening — Affects up to 70% of men after radical prostatectomy, with average loss of 1–2 cm (0.4–0.8 inches) in the first year. Over 164,000 radical prostatectomies are performed annually in the United States.
- Clinical Evidence — Toussi et al. (2021) randomized controlled trial: traction group gained 1.6 cm vs 0.3 cm in the control group (p<0.01) among 82 post-prostatectomy men
- Rehabilitation Timeline — Penile traction therapy typically begins 4–6 weeks post-surgery with urologist clearance
- Patient Satisfaction — 87% of post-prostatectomy patients would repeat traction therapy; 93% would recommend the treatment to other men
- Medical Supervision Required — All post-surgical traction protocols require coordination with the treating urologist
Understanding Prostatectomy & Penile Changes
Prostatectomy surgery involves the complete or partial removal of the prostate gland, a procedure most commonly performed to treat localized prostate cancer. Over 164,000 radical prostatectomies are performed annually in the United States, making post-operative rehabilitation a significant clinical concern. Radical prostatectomy — the standard surgical intervention in urological oncology — requires careful dissection around the urethra, bladder neck, and neurovascular bundles that course along the posterolateral surface of the prostate gland. The surgical removal of the prostate gland fundamentally alters the anatomical relationships between the corpus cavernosum, the urethra, and surrounding connective tissue structures.
Post-operative penile shortening affects up to 70% of men following radical prostatectomy. The anatomical basis for penile length loss after prostate surgery involves multiple mechanisms: surgical trauma to the neurovascular bundles compromises erectile nerve signaling, reduced penile blood flow leads to corpus cavernosum smooth muscle atrophy, and fibrotic tissue changes in the tunica albuginea alter the elastic properties of the penile shaft.
Clinicians distinguish between anatomical shortening and functional shortening after radical prostatectomy. Anatomical shortening refers to permanent structural tissue loss caused by fibrosis, smooth muscle atrophy, and collagen contracture within the corpus cavernosum and tunica albuginea. Functional shortening describes reduced erectile capacity related to nerve damage and diminished penile blood flow — a condition that may partially reverse with nerve recovery but compounds perceived length loss. Clinical evidence indicates that men who undergo radical prostatectomy may experience measurable penile shortening of 1–2 cm (0.4–0.8 inches) within the first 6–12 months following surgery.
📸 Image will appear here once uploaded
Nerve-sparing surgery techniques preserve the neurovascular bundles whenever oncologically safe, yet even nerve-sparing radical prostatectomy does not fully prevent the cascade of post-surgical tissue changes that contribute to penile shortening. The surgical trauma response triggers an inflammatory process within the corpus cavernosum that, without active rehabilitation, may progress to irreversible fibrosis and permanent length loss.
- Radical Prostatectomy (Open)
- Traditional open surgical approach that removes the entire prostate gland through an abdominal incision. Open radical prostatectomy allows direct visualization of neurovascular bundles but may involve longer post-operative healing compared to minimally invasive techniques.
- Robotic-Assisted Laparoscopic Prostatectomy
- Minimally invasive technique using robotic surgical instruments that undergo precise manipulation through small incisions. Robotic-assisted prostatectomy offers enhanced visualization and may preserve neurovascular bundle integrity more effectively, though post-operative penile shortening remains a documented concern.
- Laparoscopic Prostatectomy
- Minimally invasive surgical approach performed through small abdominal incisions using specialized instruments. Laparoscopic prostatectomy reduces overall surgical trauma but does not eliminate the risk of post-operative penile changes affecting corpus cavernosum integrity and penile blood flow restoration.
The Role of Penile Traction in Post-Prostatectomy Recovery
Penile traction therapy addresses post-prostatectomy penile shortening through the biological mechanism of mechanotransduction — the cellular process by which sustained mechanical force stimulates tissue growth and collagen remodeling at the molecular level. When applied to the penis after radical prostatectomy, calibrated traction force promotes cellular proliferation within the tunica albuginea and corpus cavernosum, helping to prevent the fibrotic tissue contracture that causes permanent length loss in untreated patients.
Penile traction therapy after prostatectomy helps preserve penile length, prevent tissue contracture, and support erectile function recovery. The 2021 randomized controlled trial by Toussi and colleagues demonstrated that structured traction protocols reduced post-surgical penile shortening significantly — the traction group gained 1.6 cm compared to just 0.3 cm in the control group — when initiated within 4–6 weeks of surgery with urologist clearance.
Structured post-prostatectomy penile rehabilitation using traction therapy serves three distinct clinical objectives. Traction force stimulates penile blood flow restoration by maintaining the corpus cavernosum smooth muscle cells in an oxygenated state, preventing the apoptosis and fibrosis cascade that follows prolonged erectile dysfunction.
Sustained mechanical stimulation through calibrated traction promotes collagen remodeling within the tunica albuginea, preserving tissue elasticity and preventing the contracture that leads to permanent anatomical shortening after radical prostatectomy.
Regular traction therapy facilitates the recovery of penile length that would otherwise be lost to post-surgical tissue changes. The combination of improved penile blood flow, maintained tissue architecture, and cellular proliferation supports both anatomical length preservation and functional erectile recovery.
📊 Clinical Evidence
The 2021 randomized controlled trial by Toussi, Ziegelmann, and Yang, published in the Journal of Urology (PMID: 34060339), demonstrated that post-prostatectomy patients using penile traction therapy gained an average of 1.6 cm (0.6 inches) in stretched penile length compared to 0.3 cm (0.1 inches) in the control group — a statistically significant difference (p<0.01). Among the 82 men enrolled in the study, 87% reported willingness to repeat the therapy and 93% would recommend penile traction to other prostatectomy patients.
The SizeGenetics device — an FDA-registered Class II medical penile traction device (FDA Registration #3005401991) — applies calibrated tension between 900–2,800 grams (8.8–27.5 Newtons) through 58-way Multi-Axis Comfort Technology. SizeGenetics was developed by Dr. Jørn Ege Siana, a Danish plastic surgeon who co-invented penile traction therapy in 1994 through Danamedic ApS, the manufacturer of penile traction devices for over 32 years with more than 1,000,000 units sold worldwide. Post-prostatectomy rehabilitation protocols typically begin with lower tension settings and gradually increase force as post-surgical tissue healing progresses under urologist supervision.
| Recovery Benefit | Mechanism | Clinical Evidence |
|---|---|---|
| Length Preservation | Mechanotransduction stimulates cellular proliferation, counteracting tissue contracture | Toussi et al. (2021): +1.6 cm traction vs +0.3 cm control in post-prostatectomy RCT |
| Tissue Contracture Prevention | Sustained traction maintains collagen fiber alignment and prevents fibrosis | Gontero et al. (2009): 1.3 cm mean gain in Peyronie's disease patients — validates traction mechanism |
| Erectile Function Support | Improved penile blood flow preserves corpus cavernosum smooth muscle viability | Toussi et al. (2021): improved IIEF (International Index of Erectile Function) scores in traction group |
| Curvature Prevention | Uniform traction prevents asymmetric scar tissue formation | Almsaoud et al. (2023) meta-analysis: 27% curvature improvement across 12 Peyronie's disease studies |
Penile traction therapy after prostatectomy functions as rehabilitation — not enhancement. The therapeutic goal for post-surgical patients focuses on maintaining pre-operative penile dimensions and facilitating erectile function recovery rather than augmenting baseline measurements. Clinical studies demonstrate that initiating penile traction within 4–6 weeks of radical prostatectomy may help prevent the progressive penile shortening observed in men who receive no rehabilitation intervention.
Clinical Evidence & Urological Studies
Multiple clinical studies have examined the role of penile traction therapy in post-prostatectomy rehabilitation and broader urological applications. The strongest direct post-prostatectomy evidence comes from the 2021 randomized controlled trial by Toussi and colleagues at the Mayo Clinic. Additional supporting research from the Peyronie's disease traction literature validates the underlying mechanotransduction mechanism — the same biological process that drives length preservation in post-surgical patients.
📸 Image will appear here once uploaded
The Toussi et al. randomized controlled trial (PMID: 34060339) enrolled 82 men (mean age 58.6 years) who had undergone radical prostatectomy. Participants were randomized to either a penile traction therapy group or a control group receiving standard post-operative care alone. After 6 months, the traction group demonstrated a statistically significant length gain of 1.6 cm (0.6 inches) compared to 0.3 cm (0.1 inches) in the control group (p<0.01). The study also concluded that penile traction therapy improved International Index of Erectile Function scores, indicating broader rehabilitative benefits beyond length preservation alone. Urological researchers recommend penile traction therapy as a component of post-prostatectomy rehabilitation protocols based on these findings.
Supporting evidence from the broader traction therapy literature validates the mechanotransduction mechanism that underpins post-prostatectomy rehabilitation. Gontero and colleagues (PMID: 19138361), publishing in the Journal of Sexual Medicine (2009), studied 15 Peyronie's disease patients using penile traction over 6 months in a Phase II prospective study. Gontero's Peyronie's disease research demonstrated a mean length gain of 1.3 cm with no significant adverse events — confirming that sustained traction safely promotes tissue growth through the same cellular mechanism applied in post-prostatectomy rehabilitation.
Key Findings from Urological Literature
Dr. Jørn Ege Siana, M.D.
Dr. Jørn Ege Siana, plastic surgeon, tissue reconstruction specialist, and co-inventor of the SizeGenetics penile traction device, applied mechanotransduction principles from reconstructive plastic surgery to develop the first penile traction device in 1994. Dr. Siana's clinical background in tissue reconstruction directly informed the graduated tension protocols now used in post-prostatectomy rehabilitation.
- Board-certified plastic surgeon, Copenhagen, Denmark
- Co-inventor of the penile traction device category (patent filed February 1995)
- Medical advisor to Danamedic ApS — Danish medical device manufacturer founded in 1988
Treatment Protocol & Timeline for Post-Surgical Use
Post-prostatectomy traction therapy follows a graduated protocol designed to align with the natural healing phases of post-operative tissue recovery. Every post-surgical traction protocol requires explicit medical clearance from the treating urologist before initiation. The recovery timeline below represents a general clinical framework — individual patient recovery may differ based on surgical approach, nerve-sparing status, and overall healing progress.
| Recovery Phase | Timeline | Traction Protocol | Key Milestones |
|---|---|---|---|
| Phase 1: Initial Healing | Weeks 0–4 | No traction — rest and surgical wound healing | Catheter removal, wound closure, urologist follow-up |
| Phase 2: Early Rehabilitation | Weeks 4–8 | Begin gentle traction at 600–900 grams for 2–3 hours daily | Medical clearance obtained, baseline measurements recorded |
| Phase 3: Progressive Traction | Months 2–4 | Increase to 900–1,200 grams for 4–6 hours daily | Progress assessment, tension adjustment, urologist coordination |
| Phase 4: Maintenance | Months 4–6+ | Full protocol at 900–2,800 grams for 4–6 hours daily | Length preservation confirmed, ongoing monitoring |
📸 Image will appear here once uploaded
Phase 1 (weeks 0–4) represents the critical initial healing period. No penile traction device should be applied during Phase 1. Surgical site integrity, catheter removal, and primary wound healing must be confirmed by the treating urologist before any rehabilitation device is introduced. Premature application of mechanical force to healing tissue may compromise surgical outcomes and increase the risk of complications.
Phase 2 (weeks 4–8) marks the beginning of early rehabilitation. Medical clearance from the urologist must be obtained before initiating traction therapy. The SizeGenetics device is applied at reduced tension settings of 600–900 grams (5.9–8.8 Newtons) for 2–3 hours per day. Baseline stretched penile length measurements are recorded at the start of Phase 2 to establish a reference point for monitoring progress throughout the rehabilitation protocol.
Phase 3 (months 2–4) involves progressive increase in traction force and daily wear time. Tension settings increase to 900–1,200 grams (8.8–11.8 Newtons) as post-surgical tissue strengthening allows safe force escalation. Daily traction duration progresses to 4–6 hours. Regular coordination with the treating urologist ensures the graduated protocol remains appropriate for each patient's individual healing trajectory.
Phase 4 (months 4–6 and beyond) represents the maintenance phase of post-prostatectomy penile rehabilitation. Full traction protocol — tension up to 900–2,800 grams for 4–6 hours daily — may be applied based on individual tolerance and urologist recommendations. Clinical studies suggest that 3–6 months of consistent traction therapy produces the most significant length preservation outcomes for post-prostatectomy patients.
Safety Considerations & Medical Coordination
Post-surgical traction therapy requires heightened attention to healing tissue integrity and ongoing communication with the treating urologist. Post-prostatectomy patients represent a population with specific safety considerations that differ from general traction therapy use. Healing tissue at the surgical site, potential changes to the urethra and bladder neck, and the ongoing recovery of neurovascular bundle function all demand careful medical oversight throughout the rehabilitation protocol.
The Toussi et al. (2021) post-prostatectomy trial reported no serious adverse events among the 82 participants who used penile traction therapy under urologist supervision. Across the broader traction therapy literature — including Peyronie's disease studies involving over 1,000 patients — no serious adverse events have been reported when traction devices are used according to medical guidelines. The overall adverse event rate of 11.2–14.4% encompasses mild, temporary effects such as skin redness and mild discomfort — all of which resolve with temporary discontinuation of traction. For post-prostatectomy patients, the risk profile remains favorable when medical clearance is obtained and the graduated protocol is followed under penile traction therapy safety and side effects guidelines.
Medical Coordination Checklist
- Obtain written medical clearance from the treating urologist before initiating any penile traction device use after prostatectomy
- Record baseline measurements — stretched penile length, flaccid length, and circumference — at the first post-clearance appointment
- Report any unusual symptoms immediately to the urologist, including persistent pain, skin breakdown, numbness, or changes at the surgical site
- Coordinate tension progression with scheduled urological follow-up appointments to ensure force escalation aligns with tissue healing
- Monitor erectile function recovery alongside traction therapy, as improved penile blood flow from traction may complement other erectile rehabilitation interventions
- Verify device specifications — use only an FDA-registered penile traction device with calibrated tension settings appropriate for post-surgical tissue
Frequently Asked Questions
When can penile traction therapy begin after prostatectomy?
Penile traction therapy typically begins 4–6 weeks after radical prostatectomy, once initial healing is complete and the treating urologist provides explicit medical clearance. The graduated protocol starts with gentle traction at 600–900 grams for 2–3 hours daily, increasing progressively over subsequent months under medical supervision.
Does penile traction therapy prevent post-prostatectomy shortening?
Clinical evidence indicates that penile traction therapy may help prevent post-prostatectomy penile shortening. The 2021 randomized controlled trial by Toussi and colleagues (PMID: 34060339), the only dedicated post-prostatectomy traction study, demonstrated that the traction group gained 1.6 cm compared to 0.3 cm in the control group after 6 months (p<0.01). Additional research on Peyronie's disease populations — including Gontero et al. (2009, PMID: 19138361) and the Almsaoud et al. (2023) meta-analysis — validates the mechanotransduction mechanism that underpins traction-based length preservation across clinical indications.
Is penile traction therapy safe after prostate cancer surgery?
Penile traction therapy demonstrates a favorable safety profile for post-prostatectomy rehabilitation when used under urologist supervision. The Toussi et al. (2021) post-prostatectomy trial reported no serious adverse events among 82 participants. Across the broader traction therapy literature — including Peyronie's disease studies involving over 1,000 patients — the adverse event rate of 11.2–14.4% encompasses mild, temporary effects that resolve upon temporary discontinuation. Medical clearance from the treating urologist is required before beginning traction therapy after any surgical procedure.
Can penile traction therapy help with erectile dysfunction after prostatectomy?
Studies suggest that penile traction therapy may support erectile function recovery following radical prostatectomy. The Toussi et al. (2021) study reported improved International Index of Erectile Function scores in the traction therapy group. Sustained traction promotes penile blood flow restoration and maintains corpus cavernosum smooth muscle viability, potentially complementing other erectile rehabilitation interventions prescribed by the treating urologist.
What type of penile traction device should be used after surgery?
Post-prostatectomy patients should use only an FDA-registered Class II medical traction device with calibrated tension settings. The SizeGenetics device, manufactured by Danamedic ApS in Denmark since 1994, delivers adjustable tension between 900–2,800 grams through 58-way Multi-Axis Comfort Technology. Using a medically certified device with precise tension control is essential for post-surgical tissue safety and rehabilitation efficacy.